1. Home
  2. CVKD vs BODI Comparison

CVKD vs BODI Comparison

Compare CVKD & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • BODI
  • Stock Information
  • Founded
  • CVKD 2022
  • BODI 1998
  • Country
  • CVKD United States
  • BODI United States
  • Employees
  • CVKD N/A
  • BODI N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • BODI Industrial Machinery/Components
  • Sector
  • CVKD Health Care
  • BODI Industrials
  • Exchange
  • CVKD Nasdaq
  • BODI Nasdaq
  • Market Cap
  • CVKD 29.5M
  • BODI 25.4M
  • IPO Year
  • CVKD 2023
  • BODI N/A
  • Fundamental
  • Price
  • CVKD $10.54
  • BODI $4.55
  • Analyst Decision
  • CVKD Strong Buy
  • BODI Buy
  • Analyst Count
  • CVKD 1
  • BODI 2
  • Target Price
  • CVKD $32.00
  • BODI $10.00
  • AVG Volume (30 Days)
  • CVKD 27.7K
  • BODI 16.5K
  • Earning Date
  • CVKD 08-11-2025
  • BODI 08-05-2025
  • Dividend Yield
  • CVKD N/A
  • BODI N/A
  • EPS Growth
  • CVKD N/A
  • BODI N/A
  • EPS
  • CVKD N/A
  • BODI N/A
  • Revenue
  • CVKD N/A
  • BODI $371,113,000.00
  • Revenue This Year
  • CVKD N/A
  • BODI N/A
  • Revenue Next Year
  • CVKD N/A
  • BODI N/A
  • P/E Ratio
  • CVKD N/A
  • BODI N/A
  • Revenue Growth
  • CVKD N/A
  • BODI N/A
  • 52 Week Low
  • CVKD $5.70
  • BODI $3.38
  • 52 Week High
  • CVKD $22.90
  • BODI $8.71
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 37.37
  • BODI 61.36
  • Support Level
  • CVKD $11.25
  • BODI $4.30
  • Resistance Level
  • CVKD $11.88
  • BODI $4.79
  • Average True Range (ATR)
  • CVKD 0.77
  • BODI 0.30
  • MACD
  • CVKD -0.03
  • BODI 0.05
  • Stochastic Oscillator
  • CVKD 2.95
  • BODI 67.27

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

About BODI The Beachbody Company Inc. Class A Common Stock

The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.

Share on Social Networks: